Therapeutic options in patients with diabetes mellitus type 2 and coronary artery disease: Intensified secondary prevention versus percutaneous or surgical revascularization;Diabetes mellitus typ 2 und koronare herzkrankheit: Intensive sekundärprävention versus perkutane oder chirurgische revaskularisierung

Deutsche Medizinische Wochenschrift

Volumn 129, Issue 24, 2004, Pages 1385-1389

  Sixt, S ^a   Schuler, G ^a   Niebauer, J ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

BODY MASS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; CORONARY STENT; DYSLIPIDEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; LIPOPROTEIN BLOOD LEVEL; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PROPHYLAXIS; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; LIPIDS; PROGNOSIS; STENTS;

EID: 3042520968     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-826879     Document Type: Review

References (49)

1. Abizaid A, Costa MA, Centemero M et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 2001; 104: 533-538
2. Aronson D, Rayfield EJ, Cheselro JH. Mechanisms determing course and outcome of diabetic patients who have acute myocardial infarction. Ann Intern Med 1997; 126: 296-306
3. Batty GD, Shipley MJ, Marmot M et al. Physical activity and cause-specific mortality in men with Type 2 diabetes/impaired glucose tolerance: evidence from the Whitehall study. Diabet Med 2002; 19: 580-588
4. Collins R, Armitage J, Parish S et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003; 361: 2005-2016
5. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 1997; 350: 461-468
6. Diegeler A, Thiele H, Falk V et al. Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery. N Engl J Med 2002; 347: 561-566
7. Feener EP, King GL. Endothelial Dysfunction in Diabetes Mellitus: Role in Cardiovascular Disease. Heart Fail Monit 2001; 1: 74-82
8. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393
9. Gohlke H, Kubler W, Mathes P et al. Positionspapier zur Primärprevention kardiovaskulärer Erkrankungen: Aktuelle Fassung vom 25.03.2003. Herausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie, Herz und Kreislauferkrankungen: Bearbeitet im Auftrag des Vorstandes durch die Projektgruppe Prävention. Z Kardiol 2003; 92: 522-523
10. Goldberg RB, Mellies MJ, Sacks FM et al. The Care Investigators. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. Circulation 1998; 98: 2513-2519
11. Haskell WL, Alderman EL, Fair JM et al. The Stanford Coronary Risk Intervention Project (SCRIP). Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. Circulation 1994; 89: 975-990
12. Helmrich SP, Ragland DR, Leung RW et al. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991; 325: 147-152
13. Hu FB, Manson JE, Stampfer MJ et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345: 790-797
14. Hu FB, Sigal RJ, Rich-Edwards JW et al. Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA 1999; 282: 1433-1439
15. Hu FB, Stampfer MJ, Solomon C et al. Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med 2001; 134: 96-105
16. Hu FB, Stampfer MJ, Haffner SM et al. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 2002; 25: 1129-1134
17. Hueb WA, Soares PR, Almeida De Oliveira S et al. Five-year follow-op of the medicine, angioplasty, or surgery study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending coronary artery stenosis. Circulation 1999; 100: 107-113
18. Investigators B. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997; 96: 1761-1769
19. Jolliffe JA, Rees K, Taylor RS et al. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2000; CD001800
20. Kolenda KD. Secondary prevention of coronary heart disease. How effective are modern therapy methods? Dtsch Med Wochenschr 2003; 128: 1849-1853
21. Laakso M, Lehto S, Penttilä I et al. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 1993; 88: 1421-1430
22. Lagerqvist B, Husted S, Kontny F et al. A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study. J Am Coll Cardiol 2002; 40: 1902-1914
23. Morice MC, Serruys PW, Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780
24. Moses JW, Leon MB, Pompa JJ et al. Angiographic and clinical outcomes after a sirolimus-eluting stent compared to a standard stent in patients with complex coronary stenosis. N Eng J Med 2003; in press
25. Niebauer J, Hambrecht R, Velich T et al. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: Role of physical exercise. Circulation 1997; 96: 2534-2541
26. Niebauer J, Hambrecht R, Velich T et al. Predictive value of lipid profile for salutary coronary angiographic changes in patients on a low fat diet and physical exercise program. Am J Cardiol 1996; 78: 163-167
27. Niebauer J, Cooke JP. Cardiovascular effects of exercise: role of endothelial shear stress. J Am Coll Cardiol 1996; 28: 1652-1660
28. Niebauer J, Maxwell AJ, Lin PS, Tsao PS, Kosek J, Bernstein D, Cooke JP. Impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training. Am J Physiol 1999; 276: H1346-H1354
29. Niebauer J, Maxwell AJ, Lin PS et al. NOS inhibition accelerates atherogenesis: reversal by exercise. Am J Physiol Heart Circ Physiol 2003; 285: H535-H540
30. Niebauer J, Dulak J, Chan JR et al. Gene transfer of nitric oxide synthase: effects on endothelial biology. J Am Coll Cardiol 1999; 34: 1201-1207
31. Ornish D, Scherwitz LW, Billings JH et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998; 280: 2001-2007
32. Parisi AF, Folland ED, Hartigan P Veterans Affairs ACME Investigators. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992; 326: 10-16
33. Peschel T, Beitz F, Tarnok A et al. Diabetes mellitus type 2 is associated with upregulation of atherogenic surface markers: Normalization through exercise training (abstr). Circulation 2002; 106: 712
34. Pyorala K, Pedersen TR, Kjekshus J et al. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997; 20: 614-620
35. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906
36. Schuler G, Hambrecht R, Schlierf G et al. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation 1992; 86: 1-11
37. Schuler G, Hambrecht R, Schlierf G et al. Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet. J Am Coll Cardiol 1992; 19: 34-42
38. Sculpher M, Smith D, Clayton T et al. Coronary angioplasty versus medical therapy for angina. Health service costs based on the second Randomized Intervention Treatment of Angina (RITA-2) trial. Eur Heart J 2002; 23: 1291-1300
39. Sobel BE, Frye R, Detre KM. Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Circulation 2003; 107: 636-642
40. Stamler J, Vaccaro O, Neaton JD et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444
41. Syvänna M, Taskinen MR. Lipids and lipoproteins as coronary risk factor in non-insulin-dependent diabetes mellitus. Lancet 1997; 350: 20-23
42. Tanasescu M, Leitzmann MF, Rimm EB, Hu FB. Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. Circulation 2003; 107: 2435-2439
43. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713
44. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350
45. Turner R, Cull C, Holman R. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomised, controlled trial on the effect of improved metabolic control on complications in NIDDM. Ann Intern Med 1996; 124: 136-145
46. Turner RC, Millns H, Neil HA et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998; 316: 823-828
47. Webster MWI, Scott RS. What cardiologists need to know about diabetes. Lancet 1997; 350: 23-28
48. Wei M, Gibbons LW, Mitchell TL et al. The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Ann Intern Med 1999; 130: 89-96
49. Wei M, Gibbons LW, Kampert JB et al. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med 2000; 132: 605-611